SQUAMOUS-CELL CARCINOMA OF THE PROSTATE - A TRANSFORMATION FROM ADENOCARCINOMA AFTER THE USE OF A LUTEINIZING-HORMONE-RELEASING HORMONE AGONIST AND FLUTAMIDE

被引：19
作者：
BRASLIS, KG
DAVI, RC
NELSON, E
CIVANTOS, F
SOLOWAY, MS
机构：
[1] UNIV MIAMI,SCH MED,DEPT UROL,MIAMI,FL 33101
[2] UNIV MIAMI,SCH MED,DEPT PATHOL,MIAMI,FL 33101
来源：
UROLOGY | 1995年 / 45卷 / 02期
关键词：
D O I：
10.1016/0090-4295(95)80028-X
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
We report a primary squamous cell carcinoma of the prostate that developed in a 57-year-old man, 3 years after treatment with leuprolide and flutamide for Stage D1 adenocarcinoma of the prostate. This is the first case that describes this transformation from adenocarcinoma to squamous cell carcinoma following the use of luteinizing hormone agonists.
引用
收藏
页码：329 / 331
页数：3
相关论文
共 50 条
[41]   THE USE OF A LUTEINIZING-HORMONE-RELEASING HORMONE (LH-RH) AGONIST IN PREMENOPAUSAL ADVANCED BREAST-CANCER [J].
WILLIAMS, MR ;
NICHOLSON, RI ;
BLAMEY, RW .
BREAST CANCER RESEARCH AND TREATMENT, 1986, 8 (01) :83-83
[42]   THE USE OF A LUTEINIZING-HORMONE-RELEASING HORMONE (LH-RH) AGONIST IN PREMENOPAUSAL ADVANCED BREAST-CANCER [J].
WILLIAMS, MR ;
WALKER, K ;
NICHOLSON, RI ;
TURKES, A ;
BLAMEY, RW ;
GRIFFITHS, K .
ANTICANCER RESEARCH, 1986, 6 (03) :380-380
[43]   A MULTICENTER TRIAL COMPARING THE LUTEINIZING-HORMONE-RELEASING HORMONE ANALOG ZOLADEX, WITH ZOLADEX PLUS FLUTAMIDE IN THE TREATMENT OF ADVANCED PROSTATE-CANCER [J].
LUNGLMAYR, G .
EUROPEAN UROLOGY, 1990, 18 :28-29
[44]   A LUTEINIZING-HORMONE-RELEASING HORMONE AGONIST DECREASES BIOLOGICAL-ACTIVITY AND MODIFIES CHROMATOGRAPHIC BEHAVIOR OF LUTEINIZING-HORMONE IN MAN [J].
EVANS, RM ;
DOELLE, GC ;
LINDNER, J ;
BRADLEY, V ;
RABIN, D .
JOURNAL OF CLINICAL INVESTIGATION, 1984, 73 (01) :262-266
[45]   TREATMENT OF ADVANCED-CARCINOMA OF THE PROSTATE WITH A DEPOT LUTEINIZING-HORMONE-RELEASING HORMONE ANALOG (ICI-118630) [J].
VANCANGH, PJ ;
OPSOMER, RJ .
JOURNAL OF UROLOGY, 1987, 137 (01) :61-64
[46]   PURIFICATION AND CHARACTERIZATION OF LUTEINIZING-HORMONE-RELEASING HORMONE FROM CODFISH BRAIN [J].
WU, P ;
ACKLAND, JF ;
LING, N ;
JACKSON, IMD .
REGULATORY PEPTIDES, 1986, 15 (04) :311-321
[47]   HUMAN PROSTATIC-CARCINOMA CELL-LINE LNCAP DEGRADES LUTEINIZING-HORMONE-RELEASING HORMONE [J].
MAGGI, R ;
MORETTI, RM ;
MARELLI, MM ;
PIMPINELLI, F ;
MOTTA, M .
INTERNATIONAL JOURNAL OF ONCOLOGY, 1995, 6 (06) :1231-1236
[48]   Drug Insight: clinical use of agonists and antagonists of luteinizing-hormone-releasing hormone [J].
Jörg B Engel ;
Andrew V Schally .
Nature Clinical Practice Endocrinology & Metabolism, 2007, 3 :157-167
[49]   Drug Insight: clinical use of agonists and antagonists of luteinizing-hormone-releasing hormone [J].
Engel, Joerg B. ;
Schally, Andrew V. .
NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM, 2007, 3 (02) :157-167
[50]   DIAGNOSTIC AND THERAPEUTIC USE OF LUTEINIZING-HORMONE-RELEASING HORMONE (LH-RH) [J].
SCHNEIDER, HPG .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1977, 297 :S71-S73
12345